Wendell Pritchett

Wharton Launches ESG Executive Education Certificate Programming

Retrieved on: 
Thursday, January 19, 2023

PHILADELPHIA, Jan. 19, 2023 /PRNewswire-PRWeb/ -- The Aresty Institute of Executive Education at the Wharton School of the University of Pennsylvania today announced the launch of a portfolio of executive certificates and programming in the environmental, social, and governance (ESG) space. Created in collaboration with the Wharton ESG Initiative, these online programs pair Wharton's world-class financial acumen with pioneering ESG research to prepare executives for the current challenges of ESG integration.

Key Points: 
  • "The future of business is changing at an incredibly accelerated rate," says Patti Williams, vice dean of Wharton Executive Education.
  • Programming options include a four-week foundational offering, Wharton ESG Essentials , for those needing to develop fluency in ESG, with an added path to continue studies for an additional four weeks in one of three Wharton ESG Executive Certificate programs — for Financial Professionals , Senior Leaders , and Strategists .
  • "We're not advocates, we're not taking a position, we're trying to help you do the analysis," says Witold Henisz, vice dean and faculty director of the Wharton ESG Initiative and academic director of Executive Education ESG Programming.
  • Wharton ESG Executive Programming begins online in April 2023 and is now accepting applications.

Foundation for Financial Planning Welcomes Six New Trustees

Retrieved on: 
Wednesday, February 8, 2023

Previously, she was a Financial Planner at SBSB Financial Advisors and Creative Planning.

Key Points: 
  • Previously, she was a Financial Planner at SBSB Financial Advisors and Creative Planning.
  • Her unique skillset and passion for helping others led her to complete Georgetown University’s financial planning certificate program and obtain her CFP®.
  • Erica is committed to making financial planning accessible to as many people as possible, including future planners and clients.
  • Hussain started his wealth management career as a client-facing financial advisor and specialized in comprehensive financial planning for the mass affluent client.

Destination XL Group, Inc. Names Dara Pauker Chief Operating Officer

Retrieved on: 
Monday, January 30, 2023

CANTON, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of men’s Big + Tall clothing and shoes, announced today that Dara Pauker joined the organization as Chief Operating Officer on January 27, 2023.

Key Points: 
  • CANTON, Mass., Jan. 30, 2023 (GLOBE NEWSWIRE) -- Destination XL Group, Inc. (NASDAQ: DXLG), the leading integrated commerce retailer of men’s Big + Tall clothing and shoes, announced today that Dara Pauker joined the organization as Chief Operating Officer on January 27, 2023.
  • Reporting to Ms. Pauker will be the Chief Stores Officer, Chief Merchandising Officer, SVP Global Sourcing, and SVP Technology.
  • Ms. Pauker has a Masters of Business Administration, Strategic Management and Marketing, from the Wharton School and an A.B.
  • She also currently serves as a Success Coach in Columbia Business School’s Chief Marketing Officer Certificate Program.

Kinnate Biopharma Inc. Adds Global Business and Oncology Expertise to Board of Directors with Appointment of Jill DeSimone as Independent Director

Retrieved on: 
Thursday, January 26, 2023

(Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision oncology company, today announced that its board of directors has appointed a new independent director, Jill DeSimone, who will join effective March 1, 2023.

Key Points: 
  • (Nasdaq: KNTE) (“Kinnate”), a clinical-stage precision oncology company, today announced that its board of directors has appointed a new independent director, Jill DeSimone, who will join effective March 1, 2023.
  • Ms. DeSimone brings more than forty years of global business expertise in life sciences to Kinnate’s board of directors.
  • Dean J. Mitchell, chairman of the Kinnate board of directors, commented, “I am honored to welcome Jill to the Kinnate board of directors.
  • “I am delighted to join the precision oncology and industry thought leaders of the Kinnate board at this important time in the company’s history,” Ms. DeSimone said.

Sun Communities, Inc. Appoints Jeff Blau to Its Board of Directors

Retrieved on: 
Wednesday, January 25, 2023

Southfield, MI, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE: SUI) (the “Company” and “Sun”), announced, effective today, that, Mr. Jeff Blau has joined the Company’s Board of Directors (the “Board”) as an independent director.

Key Points: 
  • Southfield, MI, Jan. 25, 2023 (GLOBE NEWSWIRE) -- Sun Communities, Inc. (NYSE: SUI) (the “Company” and “Sun”), announced, effective today, that, Mr. Jeff Blau has joined the Company’s Board of Directors (the “Board”) as an independent director.
  • Mr. Blau is Chief Executive Officer and a partner of Related Companies, a fully-integrated real estate firm based in New York, NY.
  • For over 33 years, he has directed and overseen new developments totaling over $60 billion in virtually every sector of the real estate industry.
  • “Sun is very pleased to welcome Jeff to our Board,” said Gary Shiffman, Chief Executive Officer.

Perella Weinberg Partners Announces New Partners

Retrieved on: 
Monday, January 23, 2023

NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Perella Weinberg Partners (Nasdaq: PWP), a leading global independent advisory firm, today announced the promotion of two Managing Directors to Partners of the Firm, effective January 1, 2023:

Key Points: 
  • NEW YORK, Jan. 23, 2023 (GLOBE NEWSWIRE) -- Perella Weinberg Partners (Nasdaq: PWP), a leading global independent advisory firm, today announced the promotion of two Managing Directors to Partners of the Firm, effective January 1, 2023:
    “We are thrilled to announce the promotions of Anthony and Cory to Partner.
  • Prior to joining Perella Weinberg Partners in 2014, Mr. Giuliano was at Nomura Securities International where he executed a variety of strategic and financing transactions for clients across consumer and retail.
  • Prior to joining Perella Weinberg Partners in 2017, Mr. Hill was with Bank of America Merrill Lynch in its Los Angeles office.
  • Mr. Hill’s previous principal investing experience includes work with Shamrock Capital Advisors and Marc Bell Capital Partners.

UBS Advisor Sonny Gulati Named to the Forbes Best-In-State Wealth Advisors list

Retrieved on: 
Tuesday, January 10, 2023

UBS Private Wealth Management announced today that Sonny Gulati , a Managing Director and Private Wealth Advisor in the firm’s Palo Alto, California office, has been named to the Forbes/SHOOK Best-In-State Wealth Advisors list for 2022.

Key Points: 
  • UBS Private Wealth Management announced today that Sonny Gulati , a Managing Director and Private Wealth Advisor in the firm’s Palo Alto, California office, has been named to the Forbes/SHOOK Best-In-State Wealth Advisors list for 2022.
  • This is the fourth consecutive year that Sonny has been named to the list.
  • Sonny has more than 30 years of experience working in the financial services industry, and has been with UBS since 2002.
  • This year's Forbes/SHOOK Research Best-In-State Wealth Advisors list is comprised of more than 6,500 advisors across the country who collectively manage $10 trillion in client assets.

Fexa Welcomes New CEO to Take the Company into the Future of Facilities Software Solutions

Retrieved on: 
Thursday, January 12, 2023

MULLICA HILL, N.J., Jan. 12, 2023 /PRNewswire-PRWeb/ -- Fexa, a SaaS solution for facility maintenance departments and service providers looking to improve efficiency and cost effectiveness of their operations, announced today that Kurt Smith has been appointed as CEO. Smith transitions into the role formerly held by CEO and company founder, Marc Balzamo, who has led Fexa since its inception in 2011. Balzamo will continue with Fexa both on the board and as the chief technology product officer (CTPO) where he will focus on critical product innovations to launch Fexa into the future and ensure the solutions meet the needs of customers for many years to come.

Key Points: 
  • Smith transitions into the role formerly held by CEO and company founder, Marc Balzamo, who has led Fexa since its inception in 2011.
  • Prior to joining Fexa, Smith worked for several years in general management as the chief product officer for FastSpring.
  • Prior to FastSpring, he served as an operating principal at Accel-KKR Consulting Group and led engagement teams for McKinsey & Company.
  • "I'm very excited to be joining Fexa at this critical time in the company's development," said Smith.

DotCom Therapy Appoints Digital Health Pioneer Dr. Omar Dawood as Chief Executive Officer

Retrieved on: 
Monday, January 9, 2023

DotCom Therapy (DCT), a leader in pediatric therapy and support, today announced the appointment of Omar Dawood, M.D., M.P.H., M.B.A. as Chief Executive Officer and board member.

Key Points: 
  • DotCom Therapy (DCT), a leader in pediatric therapy and support, today announced the appointment of Omar Dawood, M.D., M.P.H., M.B.A. as Chief Executive Officer and board member.
  • Dawood comes to DCT with a passionate outlook for high quality care and unique perspectives as a teenage stage IV cancer survivor, healthcare provider, and digital health pioneer.
  • “DotCom Therapy was founded on the guiding mission to create opportunities for children and adolescents to receive the highest quality personalized care.
  • On top of Dawood’s vast experience in digital behavioral health, he also boasts an impressive educational journey.

Oncternal Therapeutics Announces the Appointment of Jill DeSimone to the Board of Directors

Retrieved on: 
Wednesday, January 4, 2023

SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the appointment of Jill DeSimone to its board of directors.

Key Points: 
  • SAN DIEGO, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage biopharmaceutical company focused on the development of novel oncology therapies, today announced the appointment of Jill DeSimone to its board of directors.
  • “We are thrilled to have Jill join the Oncternal board of directors.
  • Prior to joining Merck, she served as senior vice president of Global Women’s Health at Teva Pharmaceutical Industries Ltd from 2012 to 2014.
  • “I am honored to join the board at Oncternal, as it continues to advance its first-in-class late-stage oncology pipeline,” said Ms. DeSimone.